Montai Health

📍 Cambridge, United States🗓 Founded 2022👥 44 employees💰 Last funded 2019
Montai Health is focused on unlocking the power of nature to create Anthromolecule™ medicines that treat and preempt a broad range of human diseases, with an initial focus on inflammatory and autoimmune diseases. Montai's CONECTA™ platform comprehensively maps Anthromolecule bioactivity across pathways that drive disease. The CONECTA platform leverages rapid and ever-growing advancements in the digitization of natural chemistry and human biology coupled with powerful computational tools for linking chemical structure and bioactivity. This confluence of biotechnologies enables Montai to build a powerful, one-of-a-kind discovery platform focused on creating safe, effective, and more human-centric medicines than ever before. Montai Health was founded in Flagship Labs in 2019. For more information, please visit www.montai.com.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2022
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Montai Health?
Montai Health has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Montai Health last raise funding?
The most recent investment in Montai Health recorded on gritt.io was in 2019.
When was Montai Health founded?
Montai Health was founded in 2022.
What industry is Montai Health in?
Montai Health operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Montai Health based?
Montai Health is headquartered in Cambridge, United States.